Project specialising in antibody screening
Adaptyv Biosystems has raised €2.5M across 2 funding rounds from 12 investors, most recently a Pre-Seed round in Feb 2022. Based in Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2022-02-14 | Pre-Seed | €2.4M | Acequia Capital,Axial,FAST,Founders,Hawktail VC,Rheingau Founders+5 more | View deal → |
| 2021-08-06 | Grant | €93k | EPFL Tech Launchpad | View deal → |
